Delving into the Latest Updates on Nanchang Gusen Biopharmaceutical Co., Ltd. with Synapse

Overview

1) To compare the pharmacokinetic properties of glycopyrrolate inhalation spray (GB SMI) and powder inhaler (DPI) in healthy subjects and evaluate the equivalence of the two dosage forms under the conditions of this study; 2) To study the safety of glycopyrrolate inhalation spray (GB SMI) in healthy subjects.

Start Date-

Sponsor / Collaborator

Shanghai Gusen Medical Co., Ltd.

[+1]

100 Clinical Results associated with Nanchang Gusen Biopharmaceutical Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Nanchang Gusen Biopharmaceutical Co., Ltd.

Login to view more data

100 Deals associated with Nanchang Gusen Biopharmaceutical Co., Ltd.

Login to view more data

100 Translational Medicine associated with Nanchang Gusen Biopharmaceutical Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 19 Dec 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

IND Approval

1

Login to view more data